W. Drobyski

发表

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

Robert H. Collins, R. Collins, J. Nemunaitis, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

J. Dipersio, D. Porter, S. Farag, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pathogenic Bhlhe40+ GM-CSF+ CD4+ T Cells Promote Indirect Alloantigen Presentation in the GI Tract during GVHD.

J. Serody, B. Vincent, R. Taneja, 2019, Blood.

Effects of Donor Vitamin A Deficiency and Pharmacologic Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-versus-Host Disease.

J. Lai, W. Drobyski, J. Dodge, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

And Mitigate Disease Severity Induced during Graft-versus-host Disease Regulatory T Cells Are + Foxp3 + Cd8

Alexandra C. Chadwick, W. Drobyski, Calvin B. Williams, 2022 .

CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity

Alexandra C. Chadwick, W. Drobyski, Calvin B. Williams, 2012, The Journal of Immunology.

Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation.

P. Hari, M. Pasquini, M. Horowitz, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.

J. Klein, J. Passweg, E. Cohen, 2008, International journal of radiation oncology, biology, physics.

Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma

P. Hari, W. Grossman, R. Komorowski, 2009, Bone Marrow Transplantation.

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

Bryon D Johnson, C. Raison, S. Cole, 2022, Brain, behavior, & immunity - health.

Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome.

P. Hari, M. Pasquini, B. Shaw, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor leukocyte infusions in acute lymphocytic leukemia

R. Collins, A. Kirk, D. Porter, 2000, Bone Marrow Transplantation.

Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.

P. Hari, M. Pasquini, M. Horowitz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

P. Hari, R. Komorowski, W. Drobyski, 2006, Blood.

Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells.

W. Guba, E. Carreira, A. Rufer, 2020, Journal of the American Chemical Society.

transplantation with unrelated donor leukocyte infusions Treatment of relapsed leukemia after unrelated donor marrow

D. Porter, R. Mick, J. Antin, 2013 .

Modulation of in vitro and in vivo T-cell responses by transferrin-gallium and gallium nitrate.

W. Drobyski, D. Majewski, C. Chitambar, 1996, Blood.

Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome.

A. Banerjee, P. Hari, M. Pasquini, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD

W. Cui, W. Drobyski, Jack Gorski, 2022, Blood advances.

Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.

R. Truitt, W. Drobyski, B. Johnson, 1993, Bone marrow transplantation.

Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases

R. Komorowski, C. Cogbill, W. Drobyski, 2011, Modern Pathology.

Donor leukocyte infusions for multiple myeloma

R. Collins, A. Kirk, D. Porter, 2000, Bone Marrow Transplantation.

Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors

Li‐Shu Wang, Yi-Wen Huang, J. Yu, 2018, International journal of cancer.

Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection.

W. Drobyski, S. Vodanovic-Jankovic, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor γδ T Lymphocytes Promote Allogeneic Engraftment Across the Major Histocompatibility Barrier in Mice

W. Drobyski, D. Majewski, 1997 .

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

M. Horowitz, N. Flomenberg, L. Baxter‐Lowe, 1994, Blood.

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation.

T. Braun, R. Collins, K. Cornetta, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Host Conditioning Is a Primary Determinant in Modulating the Effect of IL-7 on Murine Graft-versus-Host Disease1

B. Logan, R. Komorowski, W. Drobyski, 2004, The Journal of Immunology.

transplantation mice undergoing graft-versus-host disease after bone marrow weight loss, decreased survival, and impaired alloengraftment in Inhibition of nitric oxide production is associated with enhanced

O. Griffith, C. Keever, W. Drobyski, 2011 .

Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation

O. Griffith, C. Keever, W. Drobyski, 1994 .

Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose

M. Horowitz, Rőth, C. Keever, 1993 .

Signaling Through the Type 2 Cannabinoid Receptor Regulates the Severity of Acute and Chronic Graft versus Host Disease.

C. Hillard, R. Komorowski, J. Romero, 2020, Blood.

Elimination of Leukemia in the Absence of Lethal Graft-Versus-Host Disease After Allogenic Bone Marrow Transplantation

J. Gorski, W. Drobyski, S. Vodanovic-Jankovic, 2003, The Journal of Immunology.

Allogenic Bone Marrow Transplantation Lethal Graft-Versus-Host Disease After Elimination of Leukemia in the Absence of Vodanovic-Jankovic and Jack Gorski

J. Gorski, W. Drobyski, S. Vodanovic-Jankovic, 2003 .

Adoptive immunotherapy using donor leukocyte infusions to treat relapsed hematologic malignancies after allogeneic bone marrow transplantation.

W. Drobyski, 1999, Cancer treatment and research.

The role of allogeneic transplantation in high-risk acute myelogenous leukemia

W. Drobyski, 2004, Leukemia.

Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD.

C. Weaver, M. Lawlor, C. Hillard, 2017, JCI insight.

Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.

P. Hari, M. Pasquini, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

P. Hari, M. Pasquini, M. Horowitz, 2018, Haematologica.

Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.

K. Ozker, W. Drobyski, D. Majewski, 1998, Journal of immunology.

Alloengraftment Retain Their Ability to Facilitate Lethal Murine Graft-Versus-Host Disease but T Cells Have a Reduced Ability to Cause Ex Vivo Anti-CD 3 Antibody-Activated Donor

K. Ozker, W. Drobyski, D. Majewski, 1998 .

Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

A. Ferber, R. Korngold, N. Flomenberg, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Type 2 Innate Lymphoid Cell-Interleukin 9 Circuit Induces Paneth Cell Metaplasia and Small Intestinal Remodeling

N. Salzman, A. Szabo, C. Wells, 2022, bioRxiv.

Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization

L. Baxter‐Lowe, W. Drobyski, D. Majewski, 1993, Journal of clinical microbiology.

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient.

W. Drobyski, D. Majewski, D. Carrigan, 1994, The New England journal of medicine.

Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.

M. Hessner, H. Subramanian, R. Komorowski, 2009, Blood.

Emergent autoimmunity in graft-versus-host disease.

R. Komorowski, W. Drobyski, E. Tivol, 2005, Blood.

Role of the Passive Apoptotic Pathway in Graft-Versus-Host Disease1

B. Logan, R. Komorowski, W. Drobyski, 2002, The Journal of Immunology.

Graft-Versus-Host Disease Role of the Passive Apoptotic Pathway in and Maria Gendelman

B. Logan, R. Komorowski, W. Drobyski, 2002 .

Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment.

J. Gorski, B. Logan, R. Komorowski, 2006, Blood.

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

S. Ethier, Y. Datta, M. Roth, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evolving strategies to address adverse transplant outcomes associated with T cell depletion.

W. Drobyski, 2000, Journal of hematotherapy & stem cell research.

Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.

W. Drobyski, D. Majewski, G. Hanson, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions.

T. Kuzel, C. Link, R. Burt, 2003, Experimental hematology.

M. Horowitz, N. Flomenberg, C. Keever, 1993, Blood.

Toll-like receptor-9 stimulated plasmacytoid dendritic cell precursors suppress autoimmune neuroinflammation in a murine model of multiple sclerosis

F. Zavala, Viviane A. Agbogan, P. Gastineau, 2021, Scientific Reports.

Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo.

W. Dunne, M. Horowitz, E. Burd, 1993, The Journal of infectious diseases.

Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.

P. Hari, M. Pasquini, A. D’Souza, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NF- (cid:1) B as a target for the prevention of graft-versus-host disease: comparative efﬁcacy of bortezomib and PS-1145

P. Hari, R. Komorowski, W. Drobyski, 2005 .

Adoptively Transferred γδ T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice1

J. Klein, W. Drobyski, S. Vodanovic-Jankovic, 2000, The Journal of Immunology.

Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice.

J. Klein, W. Drobyski, S. Vodanovic-Jankovic, 2000, Journal of immunology.

Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.

P. Hari, M. Pasquini, A. D’Souza, 2016, Clinical lymphoma, myeloma & leukemia.

Surgical resection as definitive treatment for refractory GVHD of the colon

R. Komorowski, R. Cornell, W. Drobyski, 2012, Bone Marrow Transplantation.

The use of the polymerase chain reaction to predict for subsequent relapse in unrelated marrow transplantation for chronic myelogenous leukemia.

M. Hessner, W. Drobyski, 1998, Leukemia & lymphoma.

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population

R. Collins, D. Porter, A. Barrett, 2008, Bone Marrow Transplantation.

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

P. Hari, R. Moss, M. Pasquini, 2016, Case Reports in Medicine.

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia

M. Horowitz, L. Baxter‐Lowe, B. Camitta, 1994 .

Alpha‐1‐antitrypsin for the treatment of steroid‐refractory acute gastrointestinal graft‐versus‐host disease

P. Hari, M. Pasquini, B. Shaw, 2017, American journal of hematology.

Spontaneous regression in non‐hodgkin's lymphoma: Clinical and pathogenetic considerations

R. Qazi, W. Drobyski, R. Qazi, 1989, American journal of hematology.

Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective

P. Hari, M. Pasquini, B. Shaw, 2018, Bone Marrow Transplantation.

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

J. Klein, A. Barrett, A. Gratwohl, 2000, Blood.

Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.

J. Gottschall, W. Drobyski, J. Potluri, 1996, Bone marrow transplantation.

FOSCARNET THERAPY OF GANCICLOVIR‐RESISTANT CYTOMEGALOVIRUS IN MARROW TRANSPLANTATION

W. Drobyski, D. Carrigan, R. Ash, 1991, Transplantation.

Chapter 35: Immune Reconstitution and Tolerance

L. Belle, W. Drobyski, 2017 .

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

M. Horowitz, D. Vesole, C. Bredeson, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill

M. Irwin, C. Coe, M. Pasquini, 2021, Translational Psychiatry.

Fatal Encephalitis Due to Variant B Human Herpesvirus-6 Infection in a Bone Marrow-Transplant Recipient

W. Drobyski, D. Majewski, D. Carrigan, 1994 .

Self-Renewing Islet TCF1+ CD8 T Cells Undergo IL-27–Controlled Differentiation to Become TCF1− Terminal Effectors during the Progression of Type 1 Diabetes

David M. Schauder, Chien-Wei Lin, W. Cui, 2021, The Journal of Immunology.

Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.

P. Hari, M. Pasquini, N. Shah, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.

M. Hessner, R. Komorowski, R. Das, 2008, Blood.

Quantitative Evaluation of Post—Bone Marrow Transplant Engraftment Status Using Fluorescent- labeled Variable Number of Tandem Repeats

D. Bellissimo, M. Hessner, W. Drobyski, 2000, Molecular Diagnosis.

Estrogen receptors and the pattern of relapse in breast cancer.

W. Drobyski, J. Chuang, R. Qazi, 1984, Archives of internal medicine.

transplantation with unrelated donor leukocyte infusions Treatment of relapsed leukemia after unrelated donor marrow

R. Collins, D. Porter, R. Mick, 2013 .

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

J. Connors, R. Collins, D. Porter, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103.

L. Gordon, M. Horowitz, C. Link, 1998, Human gene therapy.

hypervariable DNA probes and HLA-DR polymorphism T-cell-depleted bone marrow transplantation, as demonstrated by Third-party-mediated graft rejection and graft-versus-host disease after

S. Thibodeau, R. Truitt, J. Gorski, 2011 .

Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism.

S. Thibodeau, R. Truitt, J. Gorski, 1989, Blood.

Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.

S. Thibodeau, J. Gottschall, M. Roth, 1992, Bone marrow transplantation.

Role of TH17 Cells and Interleukin 17 in Graft Versus Host Disease and Graft Versus Leukemia Reactivity

W. Drobyski, Xiao Chen, 2013 .

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.

M. Hessner, R. Komorowski, R. Das, 2009, Blood.

Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD.

J. Serody, B. Vincent, L. Belle, 2018, Blood.

A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

J. Serody, B. Vincent, C. Ballantyne, 2016, The Journal of clinical investigation.

Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alt

J. Klein, N. Flomenberg, D. Vesole, 2002, Blood.

Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach.

P. Hari, R. Cornell, W. Drobyski, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.

P. Hari, S. Tarima, A. D’Souza, 2021, Clinical lymphoma, myeloma & leukemia.

Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis

P. Hari, B. Shaw, A. Szabo, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.

W. Drobyski, D. Majewski, 1996, Blood.

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

R. Komorowski, W. Drobyski, Xiao Chen, 2007, Blood.

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft

P. Hari, M. Pasquini, M. Horowitz, 2017, Bone Marrow Transplantation.

Prospective T rial o f C hemotherapy a nd D onor L eukocyte Infusions f or R elapse o f A dvanced M yeloid M alignancies After A llogeneic S tem-Cell T ransplantation

T. Braun, K. Cornetta, D. Porter, 2002 .

T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.

J. Klein, C. Kabler-Babbitt, M. Hessner, 1999, Blood.

Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract

D. Porter, D. Babushok, S. Luger, 2016 .

Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma

P. Hari, M. Pasquini, M. Horowitz, 2015, Bone Marrow Transplantation.

The Role of Regulatory T Cells in the Biology of Graft Versus Host Disease

W. Drobyski, A. Beres, 2013, Front. Immunol..

Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation

P. Hari, M. Pasquini, X. Zhong, 2015, Bone Marrow Transplantation.

C. Kabler-Babbitt, M. Hessner, L. Baxter‐Lowe, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia

J. Klein, M. Hessner, W. Drobyski, 1997, British journal of haematology.

Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.

M. Hessner, L. Baxter‐Lowe, M. Roth, 1994, Genetic analysis, techniques and applications.

Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.

R. Truitt, V. Piaskowski, J. Casper, 1990, Transplantation.

marrow transplantation for chronic myelogenous leukemia graft-versus- leukemia reactivity after T-cell-depleted allogeneic Use of unrelated marrow grafts compensates for reduced

M. Hessner, N. Flomenberg, J. Casper, 2010 .

Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease

W. Drobyski, A. Rayasam, 2021, Frontiers in Immunology.

Tocilizumab for the treatment of steroid refractory graft-versus-host disease.

P. Hari, M. Pasquini, W. Saber, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease

R. Komorowski, W. Drobyski, M. Mihara, 2011, Clinical Cancer Research.

Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease

W. Drobyski, Clint Piper, 2019, Front. Immunol..

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

M. Norkin, R. Vij, M. Aljurf, 2013, Leukemia.

Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.

J. Gorski, M. Yassai, W. Drobyski, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.

G. Sandford, H. C. Morse, J. Casper, 2001, Blood.

Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?

P. Hari, B. Logan, W. Drobyski, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune reconstitution: how it should work, what's broken, and why it matters.

S. Emerson, R. Gress, W. Drobyski, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

γδ T CELLS DO NOT REQUIRE FULLY FUNCTIONAL CYTOTOXIC PATHWAYS OR THE ABILITY TO RECOGNIZE RECIPIENT ALLOANTIGENS IN ORDER TO PREVENT GRAFT REJECTION

W. Drobyski, S. Vodanovic-Jankovic, 2007 .

Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection

David M. Schauder, J. Craft, W. Cui, 2018, Nature Communications.

A colitogenic memory CD 4 + T cell population mediates gastrointestinal graft-versus-host disease

J. Serody, B. Vincent, C. Ballantyne, 2016 .

A model of TH17-associated ileal hyperplasia that requires both IL-17A and IFNγ to generate self-tolerance and prevent colitis

Y. Iwakura, N. Salzman, C. Mayne, 2018, Mucosal Immunology.

Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.

P. Hari, M. Pasquini, B. Shaw, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract

D. Porter, D. Babushok, S. Luger, 2019, Bone Marrow Transplantation.

Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and Lymphoma

P. Hari, M. Pasquini, M. Horowitz, 2014 .

Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies.

P. Hari, A. Szabo, A. D’Souza, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

J. Gorski, H. Subramanian, R. Komorowski, 2011, Blood.

PHASE I STUDY OF SAFETY AND PHARMACOKINETICS OF A HUMAN ANTICYTOMEGALOVIRUS MONOCLONAL ANTIBODY IN ALLOGENEIC BONE MARROW TRANSPLANT RECIPIENTS

H. Schran, P. Ehrlich, W. Drobyski, 1991, Transplantation.

Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade.

Weiqing Jing, W. Hallett, W. Drobyski, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections

P. Hari, M. Pasquini, B. Shaw, 2016, Bone Marrow Transplantation.

agonistic CD40 antibody administration transplant recipients from the lethal cytokine syndrome occurring after Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow

K. Pritchard, W. Murphy, B. Logan, 2013 .

Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration.

K. Pritchard, W. Murphy, B. Blazar, 2004, Blood.

Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease.

C. Uyttenhove, J. Van Snick, R. Komorowski, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Regulation of Alloresponses after Bone Marrow Transplantation Using Donor T Cells Expressing a Thymidine Kinase Suicide Gene

W. Drobyski, M. Gendelman, 2002, Leukemia & lymphoma.

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine/busulfan conditioning based allogeneic hematopoietic cell transplantation for myelofibrosis: Role of ruxolitinib in improving survival outcomes.

P. Hari, M. Pasquini, B. Shaw, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity

J. Felix, Yuhong Chen, Demin Wang, 2020, The Journal of Immunology.

O. Griffith, C. Keever, W. Drobyski, 1994, Blood.

Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)

P. Hari, M. Pasquini, M. Horowitz, 2016 .

Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination

Nicholas R. Waters, P. Hari, M. V. D. van den Brink, 2022, medRxiv.

A model of TH17-associated ileal hyperplasia that requires both IL-17A and IFNγ to generate self-tolerance and prevent colitis

Y. Iwakura, N. Salzman, C. Mayne, 2018, Mucosal Immunology.

Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease.

R. Truitt, L. Baxter‐Lowe, W. Drobyski, 1993, Blood.

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

J. Van Snick, B. Logan, R. Komorowski, 2015, Blood.

M. Hessner, M. Horowitz, N. Flomenberg, 1995, Blood.

A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.

R. Komorowski, W. Drobyski, J. Dodge, 2012, Blood.

Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions.

R. Collins, D. Porter, R. Mick, 2000, Blood.

MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATION

M. Colonna, C. Hillard, W. Cui, 2023, bioRxiv.